questionsmedicales.fr
Organisations et économie des soins de santé
Contrôle social formel
Jurisprudence
Capacité mentale
Capacité mentale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Évaluation psychologique
Tests psychométriques
Démence
Troubles cognitifs
Psychiatrie
Psychologie clinique
Échelle MMSE
Tests cognitifs
Consultation psychiatrique
Troubles mentaux
Symptômes
5
Troubles de la mémoire
Difficultés cognitives
Dépression
Troubles de l'humeur
Stress
Troubles cognitifs
Troubles du sommeil
Insomnie
Changements de comportement
Troubles affectifs
Prévention
5
Prévention des troubles mentaux
Activité physique
Nutrition
Alimentation saine
Gestion du stress
Méditation
Stimulation cognitive
Jeux de société
Suivi médical
Dépistage précoce
Traitements
5
Thérapie cognitive
Médicaments psychotropes
Réhabilitation cognitive
Thérapie occupationnelle
Inhibiteurs de la cholinestérase
Médicaments anti-démence
Thérapie de groupe
Soutien social
Exercice physique
Santé cognitive
Complications
5
Incapacité fonctionnelle
Gestion des soins
Isolement social
Santé mentale
Accidents domestiques
Sécurité
Relations interpersonnelles
Conflits familiaux
Maladies chroniques
Comorbidité
Facteurs de risque
5
Âge avancé
Antécédents familiaux
Tabagisme
Santé cognitive
Inactivité physique
Santé mentale
Traumatismes crâniens
Troubles cognitifs
Troubles de l'humeur
Dépression
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Capacité mentale : Questions médicales les plus fréquentes",
"headline": "Capacité mentale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Capacité mentale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-27",
"dateModified": "2025-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Capacité mentale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Jurisprudence",
"url": "https://questionsmedicales.fr/mesh/D007603",
"about": {
"@type": "MedicalCondition",
"name": "Jurisprudence",
"code": {
"@type": "MedicalCode",
"code": "D007603",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.706.535"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Capacité mentale",
"alternateName": "Mental Competency",
"code": {
"@type": "MedicalCode",
"code": "D016743",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jane Meschan Foy",
"url": "https://questionsmedicales.fr/author/Jane%20Meschan%20Foy",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, School of Medicine, Wake Forest University, Winston-Salem, North Carolina; foy.jane@gmail.com."
}
},
{
"@type": "Person",
"name": "Cori M Green",
"url": "https://questionsmedicales.fr/author/Cori%20M%20Green",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Weill Cornell Medicine, Cornell University, New York, New York; and."
}
},
{
"@type": "Person",
"name": "Marian F Earls",
"url": "https://questionsmedicales.fr/author/Marian%20F%20Earls",
"affiliation": {
"@type": "Organization",
"name": "Community Care of North Carolina, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Cori Green",
"url": "https://questionsmedicales.fr/author/Cori%20Green",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Weill Cornell Medicine, New York, New York; cmg9004@med.cornell.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Tic douloureux sustained by an eye tumor].",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37179479",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Adnexal neoplasms of the eye.",
"datePublished": "2024-01-26",
"url": "https://questionsmedicales.fr/article/38281687",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clindermatol.2024.01.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "OVOL1 immunohistochemical expression is a useful tool to diagnose invasion in ocular surface squamous neoplasms.",
"datePublished": "2022-07-01",
"url": "https://questionsmedicales.fr/article/35787378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.oftale.2022.06.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Lymphoma of the eye and its adnexa : Modern pathological diagnostics and systemic treatment].",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35925409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00347-022-01650-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Radio-luminescent imaging for rapid, high-resolution eye plaque loading verification.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36183146",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mp.16003"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Contrôle social formel",
"item": "https://questionsmedicales.fr/mesh/D012926"
},
{
"@type": "ListItem",
"position": 4,
"name": "Jurisprudence",
"item": "https://questionsmedicales.fr/mesh/D007603"
},
{
"@type": "ListItem",
"position": 5,
"name": "Capacité mentale",
"item": "https://questionsmedicales.fr/mesh/D016743"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Capacité mentale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Capacité mentale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Capacité mentale",
"description": "Comment évaluer la capacité mentale d'un patient ?\nQuels signes indiquent une altération de la capacité mentale ?\nQuels professionnels évaluent la capacité mentale ?\nQuelles échelles sont utilisées pour le diagnostic ?\nQuand consulter un spécialiste pour un diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Eye+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Capacité mentale",
"description": "Quels sont les symptômes d'une capacité mentale altérée ?\nLa dépression affecte-t-elle la capacité mentale ?\nComment le stress impacte-t-il la capacité mentale ?\nLes troubles du sommeil influencent-ils la capacité mentale ?\nQuels changements de comportement signalent une altération ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Eye+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Capacité mentale",
"description": "Comment prévenir l'altération de la capacité mentale ?\nL'alimentation influence-t-elle la capacité mentale ?\nLe contrôle du stress est-il important ?\nLes activités mentales préventives sont-elles efficaces ?\nLe suivi médical régulier est-il nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Eye+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Capacité mentale",
"description": "Quels traitements existent pour améliorer la capacité mentale ?\nLa rééducation cognitive est-elle efficace ?\nQuels médicaments peuvent aider à la capacité mentale ?\nLa thérapie de groupe est-elle bénéfique ?\nLes exercices physiques aident-ils la capacité mentale ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Eye+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Capacité mentale",
"description": "Quelles complications peuvent résulter d'une capacité mentale altérée ?\nL'isolement social est-il une complication fréquente ?\nLes accidents sont-ils plus fréquents chez ces patients ?\nComment la capacité mentale altérée affecte-t-elle les relations ?\nLes troubles mentaux peuvent-ils aggraver d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Eye+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Capacité mentale",
"description": "Quels sont les facteurs de risque pour une altération de la capacité mentale ?\nLe tabagisme influence-t-il la capacité mentale ?\nLe manque d'activité physique est-il un facteur de risque ?\nLes traumatismes crâniens augmentent-ils le risque ?\nLes troubles de l'humeur sont-ils des facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Eye+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la capacité mentale d'un patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des tests psychométriques et des entretiens cliniques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une altération de la capacité mentale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Confusion, désorientation, incapacité à prendre des décisions éclairées."
}
},
{
"@type": "Question",
"name": "Quels professionnels évaluent la capacité mentale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Psychologues, psychiatres et médecins généralistes sont impliqués dans l'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles échelles sont utilisées pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échelle de Mini-Mental State Examination (MMSE) est couramment utilisée."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste pour un diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si des changements de comportement ou de cognition sont observés, consultez un spécialiste."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une capacité mentale altérée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Difficultés de concentration, mémoire défaillante, jugement altéré."
}
},
{
"@type": "Question",
"name": "La dépression affecte-t-elle la capacité mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dépression peut altérer la concentration et le jugement, affectant la capacité mentale."
}
},
{
"@type": "Question",
"name": "Comment le stress impacte-t-il la capacité mentale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut entraîner des troubles de la concentration et de la mémoire."
}
},
{
"@type": "Question",
"name": "Les troubles du sommeil influencent-ils la capacité mentale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un sommeil insuffisant peut nuire à la mémoire et à la prise de décision."
}
},
{
"@type": "Question",
"name": "Quels changements de comportement signalent une altération ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Isolement social, irritabilité, et changements d'humeur fréquents peuvent être des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'altération de la capacité mentale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une vie active, équilibrée et socialement engagée aide à prévenir les troubles."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la capacité mentale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en oméga-3 et antioxydants favorise la santé cognitive."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de gestion du stress comme la méditation peuvent aider à préserver la cognition."
}
},
{
"@type": "Question",
"name": "Les activités mentales préventives sont-elles efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeux de réflexion et la lecture stimulent le cerveau et peuvent retarder le déclin."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier est-il nécessaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers permettent de détecter précocement des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour améliorer la capacité mentale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie cognitive, la médication et les exercices mentaux."
}
},
{
"@type": "Question",
"name": "La rééducation cognitive est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à restaurer certaines fonctions cognitives et à améliorer la prise de décision."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aider à la capacité mentale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs de la cholinestérase sont souvent prescrits pour les troubles cognitifs."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle favorise le soutien social et peut améliorer la cognition par l'interaction."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils la capacité mentale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé cognitive."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une capacité mentale altérée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'incapacité à gérer les finances et les soins personnels."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec une capacité mentale altérée peuvent s'isoler, aggravant leur état."
}
},
{
"@type": "Question",
"name": "Les accidents sont-ils plus fréquents chez ces patients ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une altération de la capacité mentale augmente le risque d'accidents domestiques."
}
},
{
"@type": "Question",
"name": "Comment la capacité mentale altérée affecte-t-elle les relations ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des conflits familiaux et des difficultés de communication."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux peuvent-ils aggraver d'autres maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité mentale altérée peut aggraver des maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour une altération de la capacité mentale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les antécédents familiaux et les maladies chroniques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la capacité mentale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un déclin cognitif accru et à des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Le manque d'activité physique est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inactivité physique est liée à un risque accru de déclin cognitif."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes crâniens peuvent entraîner des troubles cognitifs à long terme."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils des facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de l'humeur comme la dépression augmentent le risque de déclin cognitif."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, School of Medicine, Wake Forest University, Winston-Salem, North Carolina; foy.jane@gmail.com.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Weill Cornell Medicine, Cornell University, New York, New York; and.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Community Care of North Carolina, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Weill Cornell Medicine, New York, New York; cmg9004@med.cornell.edu.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
The Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
The American Board of Pediatrics, Chapel Hill, North Carolina; and.
Departments of Medicine and Pediatrics, School of Medicine, Tufts University, Boston, Massachusetts.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Office of Medical Services, Region Skane, Malmö, Sweden.
Department of Clinical Science, Lund University, Lund, Sweden.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Office of Medical Services, Region Skane, Malmö, Sweden.
Department of Clinical Science, Lund University, Lund, Sweden.
Department of Cardiothoracic Surgery, IKVL, Lund University, Lund, Sweden.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
School of Nursing and Midwifery, La Trobe University, Bundoora, VIC 3086, Australia.
Victorian Tuberculosis Program, Melbourne, VIC 3000, Australia.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Department of Rural Health, University of South Australia, North Terrace, Adelaide, SA 5000, Australia.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
School of Nursing and Midwifery, La Trobe University, Bundoora, VIC 3086, Australia.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
WHO Collaborating Centre for Mental Health Promotion, Prevention and Policy, Mental Health Team, Finnish Institute for Health and Welfare, Helsinki, Finland.
Faculty of Sport and Health Sciences, University of Jyvaskyla, Finland.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
WHO Collaborating Centre for Mental Health Promotion, Prevention and Policy, Mental Health Team, Finnish Institute for Health and Welfare, Helsinki, Finland.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Faculty of Sport and Health Sciences, University of Jyvaskyla, Finland.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
Faculty of Sport and Health Sciences, University of Jyvaskyla, Finland.
Central Finland Health Care District, Jyväskylä, Finland.
Publications dans "Capacité mentale" :
2 publications dans cette catégorie
Affiliations :
University of Maryland, College Park, MD, USA.
Publications dans "Capacité mentale" :
1 publication dans cette catégorie
Affiliations :
Lentis Psychiatric institute, Groningen, The Netherlands.
Publications dans "Capacité mentale" :
1 publication dans cette catégorie
Affiliations :
Lentis Psychiatric institute, Groningen, The Netherlands.
University Medical Center Groningen, University of Groningen, Rob Giel Research Center, Groningen, The Netherlands.
Publications dans "Capacité mentale" :
1 publication dans cette catégorie
Affiliations :
Addiction care North Netherlands, Groningen, The Netherlands.
NHL Stenden Hogeschool, Leeuwarden, The Netherlands.
Publications dans "Capacité mentale" :
Cancer is a major cause of morbidity and mortality in solid organ transplantation. Nonmelanoma skin cancer (NMSC) such as basocellular (BCC) and spinocellular (SCC) carcinoma, are common in renal tran...
Adnexal neoplasms of the eyelid encompass a wide variety of benign and malignant tumors of sebaceous, follicular, and sweat gland origin. Due to the specialized structures of the eyelid, these neoplas...
OVOL1 is a gene that negatively regulates mesenchymal transformation, which allows epithelial cells to invade the stroma. On the other hand, it negatively regulates c-Myc, which has a positive effect ...
Cross-sectional cohort study of 36 samples including 6 squamous papillomas, 19 conjunctival intraepithelial neoplasms, 6 squamous carcinomas and 7 normal conjunctivae were evaluated using immunohistoc...
Percentages of 98 and 100 of the OSSN, and 57 and 71% of the normal conjunctivae expressed OVOL1 and c-Myc respectively, however, the mean H-score of OVOL1 and c-Myc was higher in the OSSN than in nor...
The expression of OVOL1 is a useful tool to differentiate between a squamous carcinoma of conjunctival intraepithelial neoplasms and papilloma. OVOL1 could play a role in the invasiveness of squamous ...
Malignant lymphomas of the eye and its adnexal structures account for approximately 5-15% of extranodal lymphomas. According to anatomic and biological criteria, two large groups of lymphomas in and a...
This article gives a summary of the classification and molecular pathology of various intraocular and periocular lymphomas as well as oncological systemic treatment with a focus on primary vitreoretin...
A selective literature search was carried out in PubMed on the topic of intraocular and periocular lymphomas and own experiences are presented....
The treatment of primary vitreoretinal lymphomas (PVRL) is an interdisciplinary challenge and despite the apparently localized disease, systemic treatment concepts are necessary to reduce the high ris...
A deep understanding of the biological and molecular principles of intraocular and periocular lymphomas forms a basic prerequisite for precise diagnostics and the use of targeted systemic treatment....
Eye plaque brachytherapy is currently an optimal therapy for intraocular cancers. Due to the lack of an effective and practical technique to measure the seed radioactivity distribution, current qualit...
In this study, a fast and low-cost radio-luminescent imaging and dose calculating system to verify the seed activity distribution for differential loading was developed....
A proof-of-concept system consisting of a thin scintillator sheet coupled to a camera/lens system was constructed. A seed-loaded plaque can be placed directly on the scintillator surface with the radi...
Data analyses showed high gamma (3%/0.3 mm, global, 20% threshold) passing rates for correct seed loadings and low passing rates with distinguished high gamma value area for incorrect loadings, indica...
Radio-luminescent QA can be used to facilitate and assure the implementation of intensity-modulated, customized plaque loading....
To evaluate the presenting complaints, surgical management, surgical outcomes, complications, and postoperative visual acuity following limbal dermoid excision....
Retrospective cohort study....
Medical records of patients with limbal dermoid presenting between January 2012 and December 2020 were retrieved to extract data regarding demographics, presenting profiles including the best-correcte...
Fifty-one eyes from 50 patients (27 males) were evaluated. The median age at the time of surgery was 11.5 years (interquartile range, IQR: 0.0-45.7). The median follow-up time was 5 years (IQR: 4-6). ...
Surgical management of limbal dermoids offers promising functional and anatomic outcomes. However, postoperative astigmatism may require further follow-up and management....
To report the demographic profile, clinical presentation, and management outcomes of ocular surface squamous neoplasia (OSSN) treated with primary topical chemotherapy in a limited resource secondary ...
Retrospective interventional study of 38 eyes of 37 patients with OSSN treated with topical 1% 5-Fluorouracil (5FU), over a period of two years....
The median age at presentation with OSSN was 44 years (mean, 46 years; range 13 to 74 years). Majority (76%) were males. The most common morphological variant was placoid OSSN (18, 47%). Limbus was th...
Primary chemotherapy with topical 1% 5FU is a safe and effective management modality for OSSN at limited resource settings in rural India....
To study the efficacy and side-effect profile of topical 5-Fluorouracil (5-FU) in the treatment of ocular surface squamous neoplasia (OSSN)....
Retrospective study of 101 eyes of 100 patients treated with 5-FU with one week on and 3 weeks off regimen....
Of the 100 patients (101 eyes), the mean age at diagnosis of OSSN was 49 (median, 52 years; range, 11-87 years). History of prior intervention was noted in 6 (6%) eyes. Tumor epicenter included bulbar...
Topical 5-FU is an effective non-invasive therapy for OSSN with a minimal side-effect profile....
To investigate the effect of using non-uniform loading and notched plaques on dose distribution for eye plaques. Using EGSnrc Monte Carlo (MC) simulations, we investigate eye plaque dose distributions...
The aim of this study was to relate common toxicity endpoints with dose to the macula, optic disc, and lens for uveal melanoma patients treated with Iodine-125 Collaborative Ocular Melanoma Study (COM...
A cohort of 52 patients treated at a single institution between 2005 and 2019 were retrospectively reviewed. Demographics, dosimetry, and clinical outcomes were recorded. Univariate, relative risk, an...
By the end of follow up (Median = 3.6 years, Range = 0.4 - 13.5 years), 65 % of eyes sustained radiation retinopathy, 40 % demonstrated moderate vision decline (>5 Snellen lines lost), and 56 % develo...
Dose-effect relationships exist for the macula and optic disc with respect to the loss of visual acuity and the development of retinopathy. To better preserve vision after treatment, further research ...